Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Detemir + Aspart vs NPH + Human Soluble Insulin in T1D
NCT01486940Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2002
- Primary completion
- Oct 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 15
01
Overview
A Phase 3 trial of insulin detemir in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started Mar 2002; status: completed.
02
Drugs
insulin detemir
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01486940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01486940.